Literature DB >> 1967373

Islet-amyloid polypeptide in human plasma.

B C van Jaarsveld, W H Hackeng, M G Nieuwenhuis, D W Erkelens, R A Geerdink, C J Lips.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1967373     DOI： 10.1016/0140-6736(90)90197-d

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Islet amyloid polypeptide--a novel controversy in diabetes research.

Authors:  P Westermark; K H Johnson; T D O'Brien; C Betsholtz
Journal:  Diabetologia       Date:  1992-04       Impact factor: 10.122

2.  Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans.

Authors:  E Hartter; T Svoboda; B Ludvik; M Schuller; B Lell; E Kuenburg; M Brunnbauer; W Woloszczuk; R Prager
Journal:  Diabetologia       Date:  1991-01       Impact factor: 10.122

3.  Effect of Pramlintide on Postprandial Glucose Fluxes in Type 1 Diabetes.

Authors:  Ling Hinshaw; Michele Schiavon; Vikash Dadlani; Ashwini Mallad; Chiara Dalla Man; Adil Bharucha; Rita Basu; Jennifer R Geske; Rickey E Carter; Claudio Cobelli; Ananda Basu; Yogish C Kudva
Journal:  J Clin Endocrinol Metab       Date:  2016-03-01       Impact factor: 5.958

4.  Islet amyloid polypeptide (amylin) increases the renal excretion of calcium in the conscious dog.

Authors:  P D Miles; L J Deftos; A R Moossa; J M Olefsky
Journal:  Calcif Tissue Int       Date:  1994-10       Impact factor: 4.333

5.  Amylin increases bone volume but cannot ameliorate diabetic osteopenia.

Authors:  D F Romero; H P Bryer; B Rucinski; J A Isserow; F J Buchinsky; M Cvetkovic; C C Liu; S Epstein
Journal:  Calcif Tissue Int       Date:  1995-01       Impact factor: 4.333
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.